Squarepoint
BEAM icon

Squarepoint’s Beam Therapeutics BEAM Stock Holding History

Squarepoint’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-138,765
Closed -$2.36M – 4365
2025
Q2 		$2.36M Buy
138,765
+114,349
+468% +$1.99M ﹤0.01% 1982
2025
Q1 		$477K Sell
24,416
-130,862
-84% -$3.43M ﹤0.01% 3344
2024
Q4 		$3.85M Buy
+155,278
New +$3.96M ﹤0.01% 1850
2024
Q3 		– Sell
-9,314
Closed -$218K – 4116
2024
Q2 		$218K Sell
9,314
-45,685
-83% -$1.12M ﹤0.01% 3605
2024
Q1 		$1.82M Buy
54,999
+18,621
+51% +$580K ﹤0.01% 2145
2023
Q4 		$990K Sell
36,378
-61,364
-63% -$1.52M ﹤0.01% 2532
2023
Q3 		$2.35M Buy
+97,742
New +$2.62M 0.01% 1690
2023
Q2 		– Sell
-46,509
Closed -$1.42M – 3568
2023
Q1 		$1.42M Buy
46,509
+19,854
+74% +$784K 0.01% 1651
2022
Q4 		$1.04M Buy
26,655
+14,321
+116% +$641K ﹤0.01% 1797
2022
Q3 		$588K Sell
12,334
-78,564
-86% -$4.48M ﹤0.01% 2128
2022
Q2 		$3.52M Sell
90,898
-7,621
-8% -$303K 0.02% 860
2022
Q1 		$5.64M Buy
+98,519
New +$6.46M 0.02% 676
2021
Q4 		– Sell
-41,815
Closed -$3.64M – 3166
2021
Q3 		$3.64M Buy
41,815
+25,914
+163% +$2.6M 0.01% 920
2021
Q2 		$2.05M Sell
15,901
-20,916
-57% -$1.67M 0.01% 1173
2021
Q1 		$2.95M Buy
+36,817
New +$3.5M 0.02% 869
2020
Q4 		– Sell
-15,740
Closed -$388K – 2919
2020
Q3 		$388K Buy
15,740
+7,440
+90% +$185K 0.01% 1625
2020
Q2 		$232K Buy
+8,300
New +$179K ﹤0.01% 1752

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Squarepoint's BEAM Position: Q3 2025 in Review

Squarepoint sold out of Beam Therapeutics (BEAM) in Q3 2025, closing a stake of 138,765 shares — an estimated $2.36M sold.

Squarepoint first reported a position in BEAM in Q2 2020 and held it in 17 quarters. The position peaked at $5.64M in Q1 2022. 219 funds tracked by Wall St. Rank hold BEAM as of Q3 2025.

  • Squarepoint reported no remaining Beam Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 138,765 Beam Therapeutics shares in Q3 2025, an estimated $2.36M.
  • Squarepoint first reported a position in Beam Therapeutics in Q2 2020 and held it in 17 quarters.
  • Squarepoint's Beam Therapeutics position peaked at $5.64M in Q1 2022.
  • 219 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.